For the third calendar quarter of 2026, Clorox is projected to report revenue of $1.88 billion and adjusted EPS of $0.97, with the stock currently trading at $86.40 against an average analyst price target of $93.57. Investors are specifically monitoring organic volume growth as the company seeks to demonstrate sustainable demand recovery following significant supply chain and IT disruptions in the prior year.
This quarter represents the first full reporting period including the Purell brand following the GOJO acquisition, which is expected to significantly boost headline sales but may impact near-term profitability. Management is expected to defend its 42% gross margin target despite facing over $200 million in projected cost inflation for the current fiscal year.